Pfizer: Bacterial Infections trials

The registry lists 28 Bacterial Infections studies with Pfizer as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 1 7Phase 2 1Phase 3 9Phase 4 5No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.TerminatedNCT02202135Phase 3Results posted
• To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)CompletedNCT01689207Phase 1Results posted
• Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin InfectionsCompletedNCT01499277Phase 3Results posted
• Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT00998309Results posted
• Bioequivalence Between Two Tablet Formulations Of Doxycycline CarragenateCompletedNCT00939562Phase 4Results posted
• French Study In ICU Patients Treated With TigecyclineCompletedNCT00799591Results posted
• A Study To Assess The Effect Of Linezolid On QTc IntervalCompletedNCT00795145Phase 1Results posted
• Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of AgeCompletedNCT00488345Phase 2Results posted
• Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.CompletedNCT00366249Phase 3Results posted
• Study Evaluating the Association of Antibiotic Measures and Control of Bacterial ResistanceCompletedNCT01788449
• Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous CapsuleCompletedNCT01058824Phase 1
• An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy AdultsCompletedNCT01018641Phase 1
• Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial InfectionsCompletedNCT00678106Phase 1
• Study Evaluation Tazocin InterventionCompletedNCT00488189Phase 4
• Tazocin Intervention StudyCompletedNCT00478855Phase 4
• Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)CompletedNCT00254696Phase 4
• Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.CompletedNCT00205816Phase 3
• Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology UnitsCompletedNCT00167999
• Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive CareCompletedNCT00167986
• Study Evaluating Vancomycin-Resistant Enterococci in a Hematology UnitCompletedNCT00167960
• Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized SubjectsCompletedNCT00081744Phase 3
• Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative OrganismsCompletedNCT00079989Phase 3
• Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedNCT00079976Phase 3
• Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal InfectionCompletedNCT00044928Phase 4
• Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive BacteriaCompletedNCT00037050Phase 3
• New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)CompletedNCT00035854Phase 3
• A Study of Azithromycin in HIV-Infected PatientsCompletedNCT00002344Phase 1
• Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.CompletedNCT00002139Phase 1